Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease

Targher, 2020, NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications, Gut, 69, 1691, 10.1136/gutjnl-2020-320622 Sutti, 2020, Adaptive immunity: an emerging player in the progression of NAFLD, Nat. Rev. Gastroenterol. Hepatol., 17, 81, 10.1038/s41575-019-0210-2 El-Agroudy, 2019, Are lifestyle therapies effective for NAFLD treatment?, Trends Endocrinol. Metab., 30, 701, 10.1016/j.tem.2019.07.013 McCommis, 2017, Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis, Hepatology, 65, 1543, 10.1002/hep.29025 Feng, 2014, The machinery of macroautophagy, Cell Res., 24, 24, 10.1038/cr.2013.168 Ajoolabady, 2020, Enzyme-based autophagy in anti-neoplastic management: from molecular mechanisms to clinical therapeutics, Biochim. Biophys. Acta Rev. Cancer, 1874, 10.1016/j.bbcan.2020.188366 Tardelli, 2020, The role of metabolic lipases in the pathogenesis and management of liver disease, Hepatology, 72, 1117, 10.1002/hep.31250 Rawnsley, 2020, Lysosome impairment as a trigger for inflammation in obesity: the proof is in the fat, EBioMedicine, 56, 10.1016/j.ebiom.2020.102824 Sathyanarayan, 2017, ATGL promotes autophagy/lipophagy via SIRT1 to control hepatic lipid droplet catabolism, Cell Rep., 19, 1, 10.1016/j.celrep.2017.03.026 Zhang, 2019, TFEB mediates immune evasion and resistance to mTOR inhibition of renal cell carcinoma via induction of PD-L1, Clin. Cancer Res., 25, 6827, 10.1158/1078-0432.CCR-19-0733 Zheng, 2018, TFEB, a potential therapeutic target for osteoarthritis via autophagy regulation, Cell Death Dis., 9, 858, 10.1038/s41419-018-0909-y Levine, 2019, Biological functions of autophagy genes: a disease perspective, Cell, 176, 11, 10.1016/j.cell.2018.09.048 Lim, 2018, A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes, Nat. Commun., 9, 1438, 10.1038/s41467-018-03939-w You, 2020, Sorting Nexin 10 mediates metabolic reprogramming of macrophages in atherosclerosis through the Lyn-dependent TFEB signaling pathway, Circ. Res., 127, 534, 10.1161/CIRCRESAHA.119.315516 Bhattamisra, 2019, Multiple biological effects of an iridoid glucoside, catalpol and its underlying molecular mechanisms, Biomolecules, 10, 10.3390/biom10010032 Zhang, 2008, Rehmannia glutinosa: review of botany, chemistry and pharmacology, J. Ethnopharmacol., 117, 199, 10.1016/j.jep.2008.02.018 Xue, 2015, Pharmacokinetics and tissue distribution of Aucubin, Ajugol and Catalpol in rats using a validated simultaneous LC-ESI-MS/MS assay, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 1002, 245, 10.1016/j.jchromb.2015.08.026 Zhong, 2018, Genipin reverses HFD-induced liver damage and inhibits UCP2-mediated pyroptosis in mice, Cell Physiol. Biochem., 49, 1885, 10.1159/000493651 Fan, 2020, Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: more friend than foe, Pharmacol. Res., 159, 10.1016/j.phrs.2020.104945 Choi, 2013, Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice, Food Chem., 141, 3627, 10.1016/j.foodchem.2013.06.028 Chen, 2019, Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity, Redox Biol., 21, 10.1016/j.redox.2018.101068 Doliba, 2017, Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: protection by casein kinase 2 inhibitor, Mol. Metab., 6, 1240, 10.1016/j.molmet.2017.07.017 Song, 2020, Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate, Pharmacol. Res., 157, 10.1016/j.phrs.2020.104845 Jiang, 2019, Hepatic deficiency of Poldip2 in type 2 diabetes dampens lipid and glucose homeostasis, Metabolism, 99, 90, 10.1016/j.metabol.2019.153948 Lin, 2013, Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice, J. Hepatol., 58, 993, 10.1016/j.jhep.2013.01.011 Yan, 2018, Environmentally relevant concentrations of carbamazepine induce liver histopathological changes and a gender-specific response in hepatic proteome of Chinese rare minnows (Gobiocypris rarus), Environ. Pollut., 243, 480, 10.1016/j.envpol.2018.09.009 Matus, 2014, A new method to measure autophagy flux in the nervous system, Autophagy, 10, 710, 10.4161/auto.28434 Hartupee, 2017, Impaired protein quality control during left ventricular remodeling in mice with cardiac restricted overexpression of tumor necrosis factor, Circ. Heart Fail., 10, 10.1161/CIRCHEARTFAILURE.117.004252 Cui, 2020, The lysosomal membrane protein Lamp2 alleviates lysosomal cell death by promoting autophagic flux in ischemic cardiomyocytes, Front. Cell Dev. Biol., 8, 31, 10.3389/fcell.2020.00031 Li, 2018, TFEB nuclear export signal integrates amino acid supply and glucose availability, Nat. Commun., 9, 2685, 10.1038/s41467-018-04849-7 Hallsworth, 2019, Lifestyle modification in NAFLD/NASH: facts and figures, JHEP Rep., 1, 468, 10.1016/j.jhepr.2019.10.008 Su, 2018, Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state, Free Radic. Biol. Med., 126, 269, 10.1016/j.freeradbiomed.2018.08.024 Lahiri, 2019, Watch what you (self-) eat: autophagic mechanisms that modulate metabolism, Cell Metab., 29, 803, 10.1016/j.cmet.2019.03.003 Gonzalez-Rodriguez, 2014, Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD, Cell Death Dis., 5, 10.1038/cddis.2014.162 Lou, 2020, Hepatic CD147 knockout modulates liver steatosis and up-regulates autophagy in high-fat-diet-induced NAFLD mice, Biochem. Biophys. Res. Commun., 524, 1010, 10.1016/j.bbrc.2020.01.164 Borgeson, 2015, Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease, Cell Metab., 22, 125, 10.1016/j.cmet.2015.05.003 Kim, 2019, Poria cocus wolf extract ameliorates hepatic steatosis through regulation of lipid metabolism, inhibition of ER stress, and activation of autophagy via AMPK activation, Int. J. Mol. Sci., 20, 19 Sarkar, 2020, PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma, Autophagy, 16, 466, 10.1080/15548627.2019.1628538 Li, 2020, Sulforaphane activates a lysosome-dependent transcriptional program to mitigate oxidative stress, Autophagy, 1 Kim, 2017, Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition, Autophagy, 13, 1767, 10.1080/15548627.2017.1356977 Chandra, 2018, Aspirin induces lysosomal biogenesis and attenuates amyloid plaque pathology in a mouse model of alzheimer’s disease via PPARalpha, J. Neurosci., 38, 6682, 10.1523/JNEUROSCI.0054-18.2018 Raben, 2016, TFEB and TFE3: linking lysosomes to cellular adaptation to stress, Annu. Rev. Cell Dev. Biol., 32, 255, 10.1146/annurev-cellbio-111315-125407 Mony, 2016, A lysosome-centered view of nutrient homeostasis, Autophagy, 12, 619, 10.1080/15548627.2016.1147671 Yu, 2020, The regulation of TFEB in lipid homeostasis of non-alcoholic fatty liver disease: molecular mechanism and promising therapeutic targets, Life Sci., 246, 10.1016/j.lfs.2020.117418 Chao, 2018, Impaired TFEB-mediated lysosome biogenesis and autophagy promote chronic ethanol-induced liver injury and steatosis in mice, Gastroenterology, 155, 865, 10.1053/j.gastro.2018.05.027 Wang, 2019, Tanshinone IIA restores dynamic balance of autophagosome/autolysosome in doxorubicin-induced cardiotoxicity via targeting Beclin1/LAMP1, Cancers, 11, 910, 10.3390/cancers11070910